UniQure's experimental gene therapy offers hope for Huntington's disease, using a medical device by ClearPoint Neuro An experimental gene therapy by UniQure has shown to slow the progress of ...
The dazzling 36-month clinical data announced by uniQure (NASDAQ: QURE) showing a significant slowing of Huntington’s disease (HD) progression in patients treated with its gene therapy candidate ...
Abstract: Unmanned aerial vehicles (UAVs) have found numerous applications and are expected to bring fertile business opportunities in the next decade. Among various enabling technologies for UAVs, ...
Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.
You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
katis-smartflow / n8n-ollama-setup Public Notifications You must be signed in to change notification settings Fork 0 Star 0 ...